2000
DOI: 10.1007/s002940000132
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and RNA-binding analysis of NAD + -isocitrate dehydrogenases from Kluyveromyces lactis and Schizosaccharomyces pombe

Abstract: Krebs cycle NAD+ -isocitrate dehydrogenase (Idh) binds to the 5-UTRs of all mitochondrial mRNAs in Saccharomyces cerevisiae. We hypothesize that this leader-binding activity plays a role in translational regulation, thereby linking mitochondrial biogenesis to the need for respiratory function. Analysis of effects of leader binding on mitochondrial translation is complicated by the involvement of the enzyme in mitochondrial metabolism. We have therefore searched for an Idh altered in RNA binding, but retaining … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
1
0
0
Order By: Relevance
“…Using the ''reactome '' annotation (Joshi-Tope et al, 2005), the HeLa mRNA interactome harbors 17 enzymes of intermediary metabolism, and the extended class IV list increases this count to 46 (Table 1). In part, this list confirms earlier experiments (Cie sla, 2006;Elzinga et al, 1993Elzinga et al, , 2000Kiri and Goldspink, 2002;Liu et al, 2001;Nagy and Rigby, 1995;Nakagawa et al, 1995;Pioli et al, 2002;Shetty et al, 2004), and it also identifies metabolic enzymes not previously known as RBPs. We validated four of these as RBPs by the dual fluorescence assay (Figure 3C); ENO1 and SHMT2 were also validated by sequencing of associated RNAs (Figures 3D and 3E).…”
Section: Insights Into Mendelian Diseasesupporting
confidence: 84%
“…Using the ''reactome '' annotation (Joshi-Tope et al, 2005), the HeLa mRNA interactome harbors 17 enzymes of intermediary metabolism, and the extended class IV list increases this count to 46 (Table 1). In part, this list confirms earlier experiments (Cie sla, 2006;Elzinga et al, 1993Elzinga et al, , 2000Kiri and Goldspink, 2002;Liu et al, 2001;Nagy and Rigby, 1995;Nakagawa et al, 1995;Pioli et al, 2002;Shetty et al, 2004), and it also identifies metabolic enzymes not previously known as RBPs. We validated four of these as RBPs by the dual fluorescence assay (Figure 3C); ENO1 and SHMT2 were also validated by sequencing of associated RNAs (Figures 3D and 3E).…”
Section: Insights Into Mendelian Diseasesupporting
confidence: 84%